Korean Biotech Companies Pursue Open Innovation with Overseas Partners for Drug Discoveries
The Pulse News website reported that major Korean biotech companies have turned to open innovation with overseas partners for faster access to innovative methods and global markets. On July 13, JW Pharmaceutical signed an R&D partnership with ARCH Venture Partners in yet another unprecedented approach to open innovation following its joint research
Comments Off on Korean Biotech Companies Pursue Open Innovation with Overseas Partners for Drug Discoveries • Read this story »
More Articles
JW Group Joins Hands with U.S. Venture Capital to Promote Open Innovation
The Business Korea website reported that the JW Group has signed a business agreement with ARCH Venture Partners, a U.S. venture capital to promote open innovation with global biotech companies. This is the first time that a Korean pharmaceutical company has joined hands with a biotech and healthcare
Comments Off on JW Group Joins Hands with U.S. Venture Capital to Promote Open Innovation • Read this story »